Cargando…

Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients

Mostrar otras versiones (1)

Detalles Bibliográficos
Autores principales:	Harrington, Patrick, Doores, Katie J., Saha, Chandan, Saunders, Jamie, Child, Fiona, Dillon, Richard, Saglam, Sukran, Raj, Kavita, McLornan, Donal, Avenoso, Daniele, Kordasti, Shahram, O’Reilly, Amy, Espehana, Andreas, Lechmere, Thomas, Khan, Hataf, Malim, Michael H., Harrison, Claire, Mehra, Varun, de Lavallade, Hugues
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier Inc. 2021
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667332/ https://www.ncbi.nlm.nih.gov/pubmed/34906318 http://dx.doi.org/10.1016/j.ccell.2021.11.011

Ejemplares similares

Repeated vaccination against SARS-CoV-2 elicits robust polyfunctional T cell response in allogeneic stem cell transplantation recipients
por: Harrington, Patrick, et al.
Publicado: (2021)

Low Frequency of T Cell and Antibody Responses to Vaccination Against Sars-Cov-2 in Patients Post Allogeneic Stem Cell Transplantation in Comparison with Chronic Myeloid Malignancy Patients
por: Harrington, Patrick, et al.
Publicado: (2021)

Single dose of BNT162b2 mRNA vaccine against SARS-CoV-2 induces high frequency of neutralising antibody and polyfunctional T-cell responses in patients with myeloproliferative neoplasms
por: Harrington, Patrick, et al.
Publicado: (2021)

Single dose of BNT162b2 mRNA vaccine against severe acute respiratory syndrome coronavirus‐2 (SARS‐CoV‐2) induces neutralising antibody and polyfunctional T‐cell responses in patients with chronic myeloid leukaemia
por: Harrington, Patrick, et al.
Publicado: (2021)

Impaired humoral and T cell response to vaccination against SARS-CoV-2 in chronic myeloproliferative neoplasm patients treated with ruxolitinib
por: Harrington, Patrick, et al.
Publicado: (2022)

Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders
por: Harrington, Patrick, et al.
Publicado: (2022)

Chronic myeloid leukaemia patients at diagnosis and resistant to tyrosine kinase inhibitor therapy display exhausted T‐cell phenotype
por: Harrington, Patrick, et al.
Publicado: (2022)

Differential inhibition of T-cell receptor and STAT5 signaling pathways determines the immunomodulatory effects of dasatinib in chronic phase chronic myeloid leukemia
por: Harrington, Patrick, et al.
Publicado: (2023)

P990: T CELL RESPONSE AND OMICRON VARIANT NEUTRALISATION FOLLOWING VACCINATION AGAINST SARS-COV-2 IN PATIENTS WITH CHRONIC MYELOID DISORDERS
por: Harrington, P., et al.
Publicado: (2022)

P991: IMPAIRMENT OF TCR SIGNALLING IN PATIENTS WITH MYELOFIBROSIS TREATED WITH RUXOLITINIB
por: Harrington, P., et al.
Publicado: (2022)

Real world experience with ropeginterferon alpha-2b (Besremi) in essential thrombocythaemia and polycythaemia vera following exposure to pegylated interferon alfa-2a (Pegasys)
por: Okikiolu, Jumoke, et al.
Publicado: (2022)

Low-dose Splenic Irradiation in Conjunction With Ruxolitinib to Provide Symptomatic Relief in Heavily Treated, Advanced Stage Myelofibrosis: A Case Series From a UK Tertiary Referral Center
por: Khan, Alesia, et al.
Publicado: (2021)

Combination therapies in Myeloproliferative Neoplasms: why do we need them and how to identify potential winners?
por: McLornan, Donal, et al.
Publicado: (2013)

Mixed T cell lineage chimerism in acute leukemia/MDS using pre-emptive donor lymphocyte infusion strategy—Is it prognostic?—a single-center retrospective study
por: Sheth, Vipul, et al.
Publicado: (2021)

Large Scale Internet-based Survey of Patients With a Myeloproliferative Neoplasm: Opinions and Experiences Regarding SARS-CoV-2 (COVID-19) Vaccination Strategies in 2021
por: Saunders, Jamie, et al.
Publicado: (2021)

Ruxolitinib for the Treatment of Essential Thrombocythemia
por: Gunawan, Arief, et al.
Publicado: (2018)

JAK2 V617F: A Single Mutation in the Myeloproliferative Group of Disorders
por: McLornan, Donal, et al.
Publicado: (2006)

Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
por: Bassiony, Sarah, et al.
Publicado: (2020)

Bone marrow niche dysregulation in myeloproliferative neoplasms
por: Curto-Garcia, Natalia, et al.
Publicado: (2020)

Evaluating Cellular Polyfunctionality with a Novel Polyfunctionality Index
por: Larsen, Martin, et al.
Publicado: (2012)

Intravesical recurrence of chromophobe renal cell carcinoma
por: Kelly, Niall P., et al.
Publicado: (2023)

ChAdOx1 nCoV-19 vaccine elicits monoclonal antibodies with cross-neutralizing activity against SARS-CoV-2 viral variants
por: Seow, Jeffrey, et al.
Publicado: (2022)

State-of-the-art review: allogeneic stem cell transplantation for myelofibrosis in 2019
por: McLornan, Donal P., et al.
Publicado: (2019)

Urosepsis and the urologist!
por: Ryan, James, et al.
Publicado: (2021)

Implementation of telemedicine in response to COVID-19 in a Dublin hospital - A patient perspective
por: Horan, M., et al.
Publicado: (2021)

The Self-Assembly and Design of Polyfunctional Nanosystems
por: Kashapov, Ruslan, et al.
Publicado: (2021)

Affix polyfunctionality in French deverbal nominalizations
por: Salvadori, Justine, et al.
Publicado: (2022)

Polyfunctional catalysis in conversion of light alkenes
por: Karpova, T. R., et al.
Publicado: (2023)

Innovative strategies to improve hematopoietic stem cell transplant outcomes in myelofibrosis
por: Perram, Jacinta, et al.
Publicado: (2022)

Humoral and cellular immunogenicity to a second dose of COVID-19 vaccine BNT162b2 in people receiving methotrexate or targeted immunosuppression: a longitudinal cohort study
por: Mahil, Satveer K, et al.
Publicado: (2021)

A neutralizing epitope on the SD1 domain of SARS-CoV-2 spike targeted following infection and vaccination
por: Seow, Jeffrey, et al.
Publicado: (2022)

Age-related differences in polyfunctional T cell responses
por: Van Epps, Puja, et al.
Publicado: (2014)

RPL27A is a target of miR-595 and may contribute to the myelodysplastic phenotype through ribosomal dysgenesis
por: Alkhatabi, Heba A., et al.
Publicado: (2016)

Broad Neutralization of SARS-CoV-2 Variants, Including Omicron, following Breakthrough Infection with Delta in COVID-19-Vaccinated Individuals
por: Lechmere, Thomas, et al.
Publicado: (2022)

Polyfunctional CD4(+) T Cells As Targets for Tuberculosis Vaccination
por: Lewinsohn, Deborah A., et al.
Publicado: (2017)

Optical and Thermomechanical Properties of Doped Polyfunctional Acrylate Copolymers
por: Hanemann, Thomas, et al.
Publicado: (2018)

TMPRSS2 promotes SARS-CoV-2 evasion from NCOA7-mediated restriction
por: Khan, Hataf, et al.
Publicado: (2021)

Hydroxycarbamide effects on DNA methylation and gene expression in myeloproliferative neoplasms
por: Contreras Castillo, Stephania, et al.
Publicado: (2021)

Functionalization of heterocyclic compounds using polyfunctional magnesium and zinc reagents
por: Knochel, Paul, et al.
Publicado: (2011)

Cross metathesis of unsaturated epoxides for the synthesis of polyfunctional building blocks
por: Abderrezak, Meriem K, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1pkm191nfn2p10grout61k3t8s